Correlation Between Viridian Therapeutics and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Nuvalent, you can compare the effects of market volatilities on Viridian Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Nuvalent.
Diversification Opportunities for Viridian Therapeutics and Nuvalent
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Nuvalent is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Nuvalent go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Nuvalent
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.24 times more return on investment than Nuvalent. However, Viridian Therapeutics is 1.24 times more volatile than Nuvalent. It trades about 0.12 of its potential returns per unit of risk. Nuvalent is currently generating about 0.1 per unit of risk. If you would invest 1,198 in Viridian Therapeutics on August 27, 2024 and sell it today you would earn a total of 905.00 from holding Viridian Therapeutics or generate 75.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Nuvalent
Performance |
| Timeline |
| Viridian Therapeutics |
| Nuvalent |
Viridian Therapeutics and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Nuvalent
The main advantage of trading using opposite Viridian Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Nuvalent vs. Eliem Therapeutics | Nuvalent vs. HCW Biologics | Nuvalent vs. Scpharmaceuticals | Nuvalent vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |